Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-011505
Filing Date
2020-06-19
Accepted
2020-06-19 16:10:39
Documents
2
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1603
2 ex24.htm EX-24 10387
  Complete submission text file 0001493152-20-011505.txt   13634
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 123 WRIGHT BROTHERS DRIVE SALT LAKE CITY UT 84116
Business Address
Mann Paul Elliot (Reporting) CIK: 0001744816 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 20975738